Inhaled antibodies: formulations require specific development to overcome instability due to nebulization

ABSTRACT: Respiratory infections are life-threatening and therapeutic antibodies (Ab) have a tremendous opportunity to benefit to patients with pneumonia due to multidrug resistance bacteria or emergent virus, before a vaccine is manufactured. In respiratory infections, inhalation of anti-infectious...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayor, Alexie, Thibert, Béatrice, Huille, Sylvain, Respaud, Renaud, Audat, Héloïse, Heuzé-Vourc’h, Nathalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993445/
https://www.ncbi.nlm.nih.gov/pubmed/33768475
http://dx.doi.org/10.1007/s13346-021-00967-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993445/
https://www.ncbi.nlm.nih.gov/pubmed/33768475
http://dx.doi.org/10.1007/s13346-021-00967-w

Ejemplares similares